Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03205072 · ClinicalTrials.gov registry record
POCS in Liver Transplantation Patients
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 42
- Enrollment target
NCT03205072 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 42 participants.
The verdict
NCT03205072 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 42 participants
- Enrollment target
Study Summary
A prospective, multi-center, non-randomized, observational, consecutive case series, which will compare Endoscopic Retrograde Cholangiopancreatoscopy (ERCP) and cholangioscopy with Spy Glass Digital System (DS) procedure at 5-10 centers.
Interventions
- DEVICE Spy Glass DS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2018-01-25 |
| Est. Completion | 2022-03-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03205072
The ClinicalTrials.gov registry entry for NCT03205072 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Spy Glass DS is the first listed.
NCT03205072 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03205072 about?
NCT03205072 is a clinical study titled "POCS in Liver Transplantation Patients". A prospective, multi-center, non-randomized, observational, consecutive case series, which will compare Endoscopic Retrograde Cholangiopancreatoscopy (ERCP) and cholangioscopy with Spy Glass Digital System (DS) procedure at 5-10 centers.
What is the current status of trial NCT03205072?
This trial is currently completed. The enrollment target is 42 participants. The study started on 2018-01-25. Estimated completion is 2022-03-24.
What interventions are being tested in trial NCT03205072?
The interventions under investigation include: Spy Glass DS (DEVICE).
Who is sponsoring clinical trial NCT03205072?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.